Reducing Antibiotic Use for Culture-Negative Sepsis in a Level IV Neonatal Intensive Care Unit

医学 抗生素 抗生素管理 心理干预 抗菌管理 败血症 指南 新生儿重症监护室 重症监护医学 重症监护 急诊医学 内科学 儿科 抗生素耐药性 护理部 微生物学 病理 生物
作者
Jessica M. Lewis,Laura Nell Hodo,Jennifer Duchon,Courtney Juliano
出处
期刊:Pediatrics [American Academy of Pediatrics]
卷期号:155 (3)
标识
DOI:10.1542/peds.2023-065098
摘要

BACKGROUND AND OBJECTIVES Antibiotic use for suspected infection without a source occurs frequently in neonatal intensive care units (NICUs). Prolonged antibiotic use is associated with increased risk for late-onset sepsis, death, and emergence of multidrug-resistant bacteria. Our aim was to reduce antibiotic use for culture-negative sepsis (CNS) through interventions designed to decrease the number and length of antibiotic courses for CNS. METHODS Our team used the Model for Improvement with sequential Plan-Do-Study-Act cycles to implement interventions in our level IV NICU. These included the creation of Antibiotic Guidelines, case audits, weekly antibiotic stewardship rounds, and biweekly review of CNS cases at staff meetings. All patients who received any dose of antibiotic and who had no major congenital anomalies were included. The primary outcome measures were CNS courses and antibiotic days of therapy (DOTs) per 1000 patient days (PDs). We tracked the number of antibiotic initiation events, re-initiation events, and antibiotic spectrum index as balancing measures. RESULTS Antibiotic DOTs for CNS decreased significantly (81%) compared with baseline after study interventions. Subgroup analysis revealed this change was driven by a decrease in early-onset sepsis DOTs, with a reduction from 18.3 to 3.9 DOTs/1000 PDs. Overall antibiotic DOTs for the unit decreased from 232.5 to 176.7 DOTs/1000 PDs. There was no change in any of the prespecified balancing measures. CONCLUSIONS This quality-improvement initiative, which prioritized case review and stewardship rounds to promote guideline adherence and reduce the treatment of CNS, resulted in a decrease in antibiotic use in a level IV NICU.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
8R60d8应助ChenChen采纳,获得10
刚刚
刚刚
干红发布了新的文献求助10
2秒前
博qb完成签到,获得积分10
2秒前
3秒前
Malmever完成签到,获得积分10
3秒前
wangrblzu应助Joshua采纳,获得10
4秒前
Yanqi发布了新的文献求助10
4秒前
4秒前
5秒前
我是老大应助......采纳,获得10
6秒前
7秒前
111发布了新的文献求助10
8秒前
8秒前
Samamms发布了新的文献求助10
9秒前
1111完成签到 ,获得积分10
10秒前
舒心的饼干完成签到 ,获得积分10
11秒前
xyzhang完成签到,获得积分10
11秒前
王钰淼发布了新的文献求助10
12秒前
李爱国应助Yanqi采纳,获得10
12秒前
8R60d8应助ChenChen采纳,获得80
13秒前
我是站长才怪应助所以Sun采纳,获得20
13秒前
科研通AI5应助科研通管家采纳,获得10
13秒前
13秒前
科研通AI5应助科研通管家采纳,获得10
13秒前
科研通AI2S应助科研通管家采纳,获得10
14秒前
科研通AI2S应助科研通管家采纳,获得10
14秒前
英俊的铭应助科研通管家采纳,获得10
14秒前
猫咪老师应助科研通管家采纳,获得30
14秒前
Akim应助科研通管家采纳,获得10
14秒前
PageSeo2应助科研通管家采纳,获得20
14秒前
搜集达人应助科研通管家采纳,获得30
14秒前
沈书应助科研通管家采纳,获得10
14秒前
科研助手6应助科研通管家采纳,获得10
14秒前
猫咪老师应助科研通管家采纳,获得30
14秒前
李健应助科研通管家采纳,获得10
15秒前
PageSeo2应助科研通管家采纳,获得20
15秒前
英俊的铭应助科研通管家采纳,获得10
15秒前
coco应助科研通管家采纳,获得10
15秒前
Zbmd完成签到,获得积分10
15秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Izeltabart tapatansine - AdisInsight 800
Maneuvering of a Damaged Navy Combatant 650
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3774420
求助须知:如何正确求助?哪些是违规求助? 3320128
关于积分的说明 10198570
捐赠科研通 3034739
什么是DOI,文献DOI怎么找? 1665166
邀请新用户注册赠送积分活动 796697
科研通“疑难数据库(出版商)”最低求助积分说明 757549